CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,016 enrolled
Drug / intervention
Metabolic-bariatric surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06649578
NCT06649578N/ACompleted

Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks: Insights From a Decade-Long Cohort Study of 1016 Patients

National University Hospital, Singapore·observational·Posted Oct 21, 2024·Updated Oct 23, 2024

In Brief

An observational study evaluating Metabolic-bariatric surgery for Bariatric Surgery and 2 related conditions. Completed, enrolled 1,016 participants across 1 site.

Detailed Summary

While metabolic-bariatric surgery is a safe and well-established surgery, complications do occur and can have significant impact on the patient. With the study, the investigators aim to establish the proportion of patients that will have complications and understand what the impact of complications are on costs.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSingapore

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 21, 2024
Enrollment StartJan 1, 2010
Primary CompletionFeb 1, 2023
Study CompletionApr 1, 2023
TodayJul 2, 2026
Enrollment to primary: 13.1 yearsPosted 1.7 years ago

Interventions

Metabolic-bariatric surgeryprocedure

Our study is conducted in a predominantly high-risk Asian population that will be undergoing metabolic-bariatric surgery. The types of surgery can be divided into Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).